Aug 08, 2019
Lawsuits against drugmaker Gilead over HIV medications containing TDF to be coordinated before a single judge in California, following motion by Grant & Eisenhofer
Jul 08, 2019
Grant & Eisenhofer Brings Mass Tort Lawsuits against Drugmaker Gilead over HIV Medications Containing TDF, Suits Move Forward in California State Court
May 14, 2019
Hilliard & Shadowen, LLP Report Coalition Of Consumers, Activists, And Payors Sues Gilead And Other Manufacturers For Anticompetitive Practices On HIV Medicines
Apr 29, 2019
Janssen Announces Submission of New Drug Application to U.S. FDA For the First Monthly, Injectable, Two-Drug Regimen of Rilpivirine and Cabotegravir for Treatment of HIV
Apr 19, 2019
Mass Tort Alleges Gilead Sciences, Inc. Withheld Safer Drugs From HIV/AIDS Patients, Manipulated Patent Timing for Profit, Announces Jenner Law
Apr 09, 2019
Global Antiretroviral Drugs Market 2013-2019 & 2023 - Multi-Class Drug Combinations are Predicted to Hold their Dominant Position in the Market
Oct 03, 2018
Hong Kong Department of Health Approves Biktarvy(R) (bictegravir, emtricitabine, tenofovir alafenamide)
Jul 17, 2018
Janssen Announces U.S. FDA Approval of SYMTUZA(TM) (D/C/F/TAF), the First and Only Complete Darunavir-Based Single-Tablet Regimen for the Treatment of HIV-1 Infection
Aug 10, 2017
Mylan Advances Access in the Fight Against HIV with the Launch of Three Generic Antiretroviral Medicines in Canada
Jul 25, 2017
ViiV Healthcare Announces Superior Efficacy of Dolutegravir Versus Lopinavir/Ritonavir in Second-line HIV Treatment in Resource-limited Settings